Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.6496
Delayed Data
As of Sep 23
 +0.0291 / +4.69%
Today’s Change
0.39
Today|||52-Week Range
4.24
-77.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2006

2007

2008

2009
Revenue and IncomeOther Operating Income46.0M549.0K0.000.00
 
 
 
Net Revenues46.0M549.0K0.000.00
 
 
 
Cost of Goods Sold45.5M409.0K0.000.00
 
 
 
Depreciation And Amortization0.0086.0K2.7K3.6K
 
 
 
 
 
Operating ExpensesGross Income528.0K54.0K-2.7K-3.6K
 
 
 
 
 
Other Operating Expenses0.00289.0K1.6M1.6M
 
 
 
 
Total Operating Expenses47.8M784.0K1.6M1.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.8M-235.0K-1.6M-1.6M
 
 
 
 
 
Extraordinary Credit0.000.001.6M0.00
 
 
Extraordinary Charge0.000.000.00-80.0K
 
 
Interest Expense On Debt1.4M55.0K4.9K2.4K
 
 
 
 
 
Interest Expense Total1.4M55.0K4.9K2.4K
 
 
 
 
 
Other Expenses3.3M55.0K-1.4K2.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income101.0K-185.0K178.5K-1.5M
 
 
 
 
 
Discontinued Operations0.000.00-716.3K-130.3K
 
 
 
Extraordinary Items0.000.000.001.2M
 
 
Net Income83.0K-185.0K-537.9K-1.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS--3.7M3.7M3.7M
 
 
 
 
Shares To Calculate EPS Diluted--3.7M3.7M3.7M
 
 
 
 
 
Earnings Per ShareEPS$0.02-$0.04-$0.14-$0.46
 
 
 
 
 
EPS Diluted$0.02-$0.04-$0.14-$0.46